drugset / Trial / NCT02257957
Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
RandomizedParallel-groupOpen-labelTreatment
Summary
Dry eye is a chronic condition that decreases function and affect visual function with severe discapacity until now treatments are based in artificial eye drops. Platelet rich plasma has emerged as a strategy for cellular restoration, the purpose of this study is to evaluate their effects in lacrimal production and safety of this intervention in patients with severe dry eye.
Timeline
- Start
- 2014-11-30
- Primary completion
- 2015-09-30
- Completion
- 2016-04-20
Outcome
Met primary endpoint
paper The intervention group showed improvements in all primary outcome measures when compared with the control group, including a reduction in corneal staining (p<0.001), PMID 29970389 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | — | — |
| Comparator | Hyaluronic Acid | Other / unclassified | — | Topical |